Citi Drops Merck to “Hold” — From “Buy” — In Aft-Cast


Here it is, from The Street.com:

. . . .Merck downgraded at Citigroup from Buy to Hold, Citigroup said. $39 price target. Company is halting progress on Vorapaxar, which was its best near-term prospect. . . .

Ya’ think? I’ve said $37 was fully valued for over a year — while all the others pegged $45 and above as full value on Merck.

Time, and tide, love — time, and tide. . . .”

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s